Major Bleeding Events Are Stronger Predictors of Long-Term Mortality Than Coronary Events in Secondary Prevention Therapy for Ischaemic Heart Disease

Table 2

Clinical events during follow-up of patients with ischaemic heart disease.

Clinical events	Cumulative incidence, n (%)
All-cause death	135 (10.9%)
Cardiac death	18 (1.5%)
MI	20 (1.6%)
AP	57 (4.6%)
Any lesion revascularisation	56 (4.5%)
CHF	37 (3.0%)
VT/VF	15 (1.2%)
Ischaemic stroke	13 (1.1%)
MACCE	246 (19.8%)
Coronary event	195 (15.7%)
Bleeding events	Cumulative incidence, n (%)
All-cause bleeding	32 (2.6%)
Intracranial haemorrhage	11 (0.9%)
Gastrointestinal bleeding	19 (1.5%)
Other major bleeding events	2 (0.2%)

Values are presented as mean ± standard deviation, unless otherwise indicated. MI: myocardial infarction; AP: angina pectoris; CHF: congestive heart failure; VT/VF: ventricular tachycardia/fibrillation; and MACCE: major adverse cardiac and cerebrovascular events.